Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival

Elizabeth M. Azzato, Jonathan Tyrer, Peter A. Fasching, Matthias W. Beckmann, Arif B. Ekici, Rüdiger Schulz-Wendtland, Stig E. Bojesen, Børge G. Nordestgaard, Henrik Flyger, Roger L. Milne, José Ignacio Arias, Primitiva Menéndez, Javier Benítez, Jenny Chang-Claude, Rebecca Hein, Shan Wang-Gohrke, Heli Nevanlinna, Tuomas Heikkinen, Kristiina Aittomäki, Carl BlomqvistSara Margolin, Arto Mannermaa, Veli Matti Kosma, Vesa Kataja, Jonathan Beesley, Xiaoqing Chen, Georgia Chenevix-Trench, Fergus J. Couch, Janet E. Olson, Zachary S. Fredericksen, Xianshu Wang, Graham G. Giles, Gianluca Severi, Laura Baglietto, Melissa C. Southey, Peter Devilee, Rob A.E.M. Tollenaar, Caroline Seynaeve, Montserrat García-Closas, Jolanta Lissowska, Mark E. Sherman, Kelly L. Bolton, Per Hall, Kamila Czene, Angela Cox, Ian W. Brock, Graeme C. Elliott, Malcolm W.R. Reed, David Greenberg, Hoda Anton-Culver, Argyrios Ziogas, Manjeet Humphreys, Douglas F. Easton, Neil E. Caporaso, Paul D.P. Pharoah

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival'. Together they form a unique fingerprint.

Medicine & Life Sciences